Takeda Pharmaceutical Company Limited Income From Subleasing Rightofuse Assets
Takeda Pharmaceutical Company Limited (TAK) reported Income From Subleasing Rightofuse Assets of JPY 3.58 billion for the 12-month period ending 2019-03-31, per its 20-F filed 2021-06-29.
Discontinued › Income Statement › Other Income
ifrs-full:IncomeFromSubleasingRightofuseAssets · last filed 2021-06-29
| Period end | Income From Subleasing Rightofuse Assets 12 month |
|---|---|
| 2019-03-31 | 3.58B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 2.49B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 109.00M JPY 20-F · filed 2019-06-27 |